Mammary Gland Growth and Development from the Postnatal Period to Postmenopause: Ovarian Steroid Receptor Ontogeny and Regulation in the Mouse

Journal of Mammary Gland Biology and Neoplasia

Volumn 3, Issue 1, 1998, Pages 7-22

  Fendrick, James L ^a   Raafat, Ahmed M ^a   Haslam, Sandra Z ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Development; Estrogen receptor; Mammary gland; Progesterone receptor

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; PROGESTERONE; PROGESTERONE RECEPTOR;

ANIMAL; BREAST; CYTOLOGY; FEMALE; HUMAN; MOUSE; OVARY; PHYSIOLOGY; POSTMENOPAUSE; REVIEW; UDDER;

ANIMALS; BREAST; ESTROGENS; FEMALE; HUMANS; MAMMARY GLANDS, ANIMAL; MICE; OVARY; POSTMENOPAUSE; PROGESTERONE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 0031597934     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018766000275     Document Type: Article

References (96)

1. S. Z. Haslam (1987). Role of sex steroid hormones in normal mammary gland function. In M. C. Neville and C. W. Daniel (eds.), The Mammary Gland, Development, Regulation and Function, Plenum Press, New York, pp. 499-533.
2. S. Z. Haslam and G. Shyamala (1979). Effect of oestradiol on progesterone receptors in normal mammary glands and its relationship to lactation. Biochem. J. 182:127-131.
3. S. Z. Haslam and G. Shyamala (1979). Progesterone receptors in normal mammary glands of mice: Characterization and relationship to development. Endocrinology 105:786-795.
4. S. Z. Haslam and G. Shyamala (1980). Progesterone receptors in normal mammary gland: receptor modulations in relation to differentiation. J. Cell. Biol. 86:730-737.
5. 3H/HeCrg1 mouse. J. Natl. Cancer Inst. 21:1039-1063.
6. S. Z. Haslam (1989). The ontogeny of mouse mammary gland responsiveness to ovarian steroid hormones. Endocrinology 125:2766-2772.
7. S. Z. Haslam (1988). Acquisition of estrogen-dependent progesterone receptors by normal mouse mammary gland. Ontogeny of mammary progesterone receptors. J. Steroid Biochem. 31:9-13.
8. S. Z. Haslam (1988). Progesterone effects on deoxyribonucleic acid synthesis in normal mammary glands. Endocrinology 122:464-470.
9. S. Wang, L. J. Counterman, and S. Z. Haslam (1990). Progesterone action in normal mouse mammary gland. Endocrinology 127:2183-2189.
10. L. R. Lund, J. Romer, N. Thomasset, H. Solberg, C. Pyke, M. J. Bissell, K. Dano, and Z. Werb (1996). Two distinct phases of apoptosis in mammary gland involution: Proteinase-independent and -dependent pathways. Development 122:181-193.
11. A. M. Raafat, J. Song, J. M. Bennett, L. J. Hofseth, and S. Z. Haslam (1997). Enhanced proliferative response to estrogen in normal mouse mammary gland after long-term ovariectomy. (submitted).
12. R. Narbaitz, W. E. Stumpf, and M. Sar (1980). Estrogen receptors in mammary gland primordia of fetal mouse. Anat. Embryol. 158:161-166.
13. S. Z. Haslam and K. A. Nummy (1992). The ontogeny and cellular distribution of estrogen receptors in normal mouse mammary gland. J. Steroid Biochem. Mol. Biol. 42:589-595.
14. C. W. Daniel, G. B. Silberstein, and P. Strickland (1987). Direct action of 17 beta-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography. Cancer Res. 47:6052-6057.
15. T. G. Muldoon (1970). Mouse mammary tissue estrogen receptors: Ontogeny and molecular heterogeneity. In T. H. Hamilton, J. H. Clark and W. A. Sadler (eds.). Ontogeny of Receptors and Reproductive Hormone Action, Raven Press, New York, pp. 225-247.
16. S. Z. Haslam and G. Shyamala (1981). Relative distribution of estrogen and progesterone receptors among the epithelial, adipose, and connective tissue components of the normal mammary gland. Endocrinology 108:825-830.
17. W. P. Bocchinfuso and K. S. Korach (1997). Mammary gland development and tumorigenesis in estrogen receptor knockout mice. J. Mam. Gland Biol. Neoplasia 2:323-334.
18. K. S. Korach, J. F. Couse, S. W. Curtis, T. F. Washburn, J. Lindzey, K. S. Kimbro, E. M. Eddy, S. Migliaccio, S. M. Snedeker, D. B. Lubahn, D. W. Schomberg, and E. P. Smith (1996). Estrogen receptor gene disruption: Molecular characterization and experimental and clinical phenotypes. Rec. Prog. Harm. Res. 51:159-188.
19. G. R. Cunha, P. Young, Y. K. Hom, P. S. Coole, J. A. Taylor, and D. R. Lubahn (1997). Elucidation of a role for stromal steroid hormone receptors in mammary gland growth and development using tissue recombination experiments. J. Mam. Gland Biol. Neoplasia 2:393-402.
20. 125I] progestin. Endocrinology 123:2382-2389.
21. S. Z. Haslam, L. J. Counterman, and A. R. St. John (1993). Hormonal basis for acquisition of estrogen-dependent progesterone receptors in the normal mouse mammary gland. Steroid Biochem. (Life Sci. Adv.) 12:27.
22. G. Shyamala, W. Schneider, and D. Schott (1990). Developmental regulation of murine mammary progesterone receptor gene expression. Endocrinology 126:2882-2889.
23. S. Z. Haslam, L. J. Counterman, and K. A. Nummy (1993). Effects of epidermal growth factor, estrogen, and progestin on DNA synthesis in mammary cell in vivo are determined by the developmental state of the gland. J. Cell. Physiol. 155:72-78.
24. J. P. Lydon, F. J. DeMayo, C. R. Funk, S. K. Mani, A. R. Hughes, C. J. Montgomery, G. Shyamala, O. M. Conneely, and B. W. O'Malley (1995). Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev. 9:2266-2278.
25. R. C. Humphreys, J. Lydon, B. W. O'Malley, and J. M. Rosen (1997). Mammary gland development is mediated by both stromal and epithelial progesterone receptors. Mol. Endocrinol 11:801-811.
26. G. B. Silberstein, K. V. Horn, G. Shyamala, and C. W. Daniel (1996). Progesterone receptors in the mouse mammary duct: Distribution and developmental regulation. Cell Growth Diff. 7:945-952.
27. E. M. Keough and B. G. Wood (1979). Mammary gland development during pregnancy in dwarf mouse mutant, little. Tissue Cell 11:773-780.
28. R. Das and B. K. Vonderhaar (1997). Prolactin as a mitogen in mammary cells. J. Mam. Gland. Biol. Neoplasia 2:29-39.
29. K. B. Horwitz and W. L. McGuire (1978). Actinomycin D prevents nuclear processing of estrogen receptor. J. Biol. Chem. 253:6319-6322.
30. K. B. Horwitz and W. L. McGuire (1978). Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor. J. Biol. Chem. 253:2223-2228.
31. L. D. Read, G. L. Greene, and B. S. Katzenellenbogen (1989). Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists and growth factors. Mol. Endocrinol 3:295-304.
32. M. Saceda, M. E. Lippman, P. Chambon, R. L. Lindsey, M. Ponglikitmongkol, M. Puente, and M. B. Martin (1988). Regulation of the estrogen receptor in MCF-7 cells by estradiol. Mol. Endocrinol. 2:1157-1162.
33. A. Berkenstam, H. Glaumann, M. Martin, J. A. Gustafsson, and G. Norstedt (1989). Hormonal regulation of estrogen receptor messenger ribonucleic acid in T47Doc and MCF-7 breast cancer cells. Mol. Endocrinol. 3:22-28.
34. G. Shyamala, W. Schneider, and M-C. Guiot (1992). Estrogen dependent regulation of estrogen receptor gene expression in normal mammary gland and its relationship to estrogenic sensitivity. Receptor. 2:121-128.
35. M. Edery, M. McGrath, L. Larson, and S. Nandi (1984). Correlation between in vitro growth and regulation of estrogen and progesterone receptors in rat mammary epithelial cells. Endocrinology 115:1691-1697.
36. T. G. Muldoon (1981). Interplay between estradiol and prolactin in the regulation of steroid hormone receptor levels, nature and functionality in normal mouse mammary tissue. Endocrinology 109:1339-1346.
37. M. Edery, W. Imagawa, L. Larson, and S. Nandi (1985). Regulation of estrogen and progesterone receptor levels in mouse mammary epithelial cells grown in serum-free collagen gel culture. Endocrinology 116:105-112.
38. S. Z. Haslam, L. J. Counterman, and K. A. Nummy (1992). EGF receptor regulation in normal mouse mammary gland. J. Cell. Physiol. 152:553-557.
39. S. Z. Haslam (1991). Stromal-epithelial interactions in normal and neoplastic mammary gland. Cancer Treat. Res. 53:401-420.
40. K. Hoshino (1978). In A. Yokoyama, H. Mizuno, and H. Nagasawa (eds.), Physiology of Mammary Glands. University Park Press, Maryland, pp. 163-228.
41. S. Z. Haslam and L. J. Counterman (1991). Mammary stroma modulates hormonal responsiveness of mammary epithelium in vivo in the mouse. Endocrinology 129:2017-2023.
42. S. Coleman, G. B. Silberstein, and C. W. Daniel (1988). Ductal morphogenesis in the mouse mammary gland: Evidence supporting a role for epidermal growth factor. Dev. Biol. 127:304-315.
43. S. Z. Haslam (1988). Local versus systemically mediated effects of estrogen on normal mammary epithelial cell deoxyribonucleic acid synthesis. Endocrinology 122:860-867.
44. G. B. Silberstein, K. V. Horn, G. Shyamala, and C. W. Daniel (1994). Essential role of endogenous estrogen in directly stimulating mammary growth demonstrated by implants containing pure antiestrogens. Endocrinology 134:84-90.
45. B. K. Vonderhaar (1984). Hormones and growth factors in mammary gland development. In C. M. Veneziale (ed.), Control of Cell Growth and Proliferation, Van Nostrand-Reinhold, New York, pp. 11-33.
46. G. Scheffield and C. W. Welch (1987). Influence of submandibular salivary glands on hormone responsiveness of mouse mammary glands. Proc. Soc. Exp. Med. 186:368-377.
47. B. K. Vonderhaar (1987). Local effects of EGF, αTGF and EGF-like growth factors on lobuloalveolar development in the mouse mammary gland in vivo. J. Cell. Physiol. 132:581-584.
48. M. Snedeker, C. F. Brown, and R. P. DiAugustine (1991). Expression and functional properties of transforming growth factor alpha and epidermal growth factor during mouse mammary gland ductal morphogenesis. Proc. Natl. Acad. Sci. USA 88:276-280.
49. D. S. Liscia, G. Merlo, F. Ciardiello, N. Kim, G. H. Smith, R. Callahan, and D. S. Salomon (1990). Transforming growth factor-alpha messenger RNA localization in the developing adult rat and human mammary gland by in situ hybridization. Dev. Biol. 140:123-131.
50. C. W. Daniel and G. B. Silberstein (1987). Postnatal development of the rodent mammary gland. In M. C. Neville and C. W. Daniel (eds.), The Mammary Gland. Development, Regulation and Function, Plenum Press, New York, pp. 3-36.
51. G. Shyamala and A. Ferenczy (1984). Mammary fat pad may be a potential site for initiation of estrogen action in normal mouse mammary glands. Endocrinology 115:1078-1081.
52. D. P. Ankrapp, J. M. Bennett, and S. Z. Haslam (1998). The role of epidermal growth factor in the acquisition of ovarian steroid hormone responsiveness in the normal mouse mammary gland. J. Cell Physiol. 174:251-260.
53. D. M. Ignar-Trowbridge, K. G. Nelson, M. C. Bidwell, S. W. Curtis, T. F. Washburn, J. A. McLachlan, and K. S. Korach (1992). Coupling of dual signaling pathways: EGF action involves the estrogen receptor. Proc. Natl. Acad. Sci. USA 89:4658-4662.
54. S. W. Curtis, T. Washburn, C. Sewall, R. DiAugustine, J. Lindzey, J. F. Couse, and K. S. Korach (1996). Physiological coupling of growth factor and steroid receptor signaling pathways: Estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor. Proc. Natl. Acad. Sci. USA 93:12626-12630.
55. D. M. Ignar-Trowbridge, C. T. Teng, K. A. Ross, M. G. Parker, K. S. Korach, and J. A. McLachlan (1993). Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Mol. Endocrinol. 7:992-998.
56. B. S. Katzenellenbogen and M. J. Norman (1990). Multihormonal regulation of the progesterone receptor in MCF-7 human breast cancer cells: Interrelationships among insulin/insulin like growth factor-1, serum, and estrogen. Endocrinology 126:891-898.
57. G. Bunone, P. A. Briand, R. J. Miksicek, and D. Picard (1996). Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J. 15:2174-2183.
58. B. S. Katzenellenbogen (1996). Estrogen receptors: Bioactivities and interactions with cell signaling pathways. Biol. Reprod. 54:287-293.
59. K. J. Fowler, F. Walker, W. Alexander, M. L. Hibbs, E. C. Nice, R. M. Bohmer, G. B. Mann, C. Thumwood, R. Maglitto, J. A. Danks, R. Chetty, A. W. Burgess, and A. R. Dunn (1995). A mutation in the epidermal growth factor receptor in waved-2 mice has a profound effect on receptor biochemistry that results in impaired lactation. Proc. Natl. Acad. Sci. USA 92:1465-1469.
60. G. G. J. M. Kuiper and A. O. Brinkman (1994). Steroid hormone receptor phosphorylation: is there a physiological role? Mol. Cell. Endocrinol. 100:103-107.
61. N. L. Weigel, W. Bai, Y. Zhang, C. A. Beck, D. P. Edwards, and A. Poletti (1995). Phosphorylation and progesterone receptor function. J. Steroid Biochem. Mol. Biol. 53:509-514.
62. G. S. Takimoto, A. R. Hovland, D. M. Tasset, M. Y. Melville, L. Tung, and K. B. Horwitz (1996). Role of phosphorylation on DNA binding and transcriptional functions of human progesterone receptors. J. Biol. Chem. 271:13308-13316.
63. P. J. Keely, J. E. Wu, and S. A. Santoro (1995). The spatial and temporal expression of the α2β1 integrin and its ligands, collagen I, collagen IV, and laminin, suggests important roles in mouse mammary morphogenesis. Differentiation 59:1-13.
64. C. H. Streuli, C. Schmidhauser, N. Bailey, P. Yurchenko, A. P. Skubits, C. Roskelley, and M. J. Bissell (1995). Laminin mediates tissue-specific gene expression in mammary epithelia. J. Cell Biol. 129:591-603.
65. C. Q. Lin and M. J. Bissell (1993). Multi-faceted regulation of cell differentiation by extracellular matrix. FASEB J. 7:737-743.
66. J. Xie and S. Z. Haslam (1997). Extracellular matrix regulates ovarian hormone-dependent proliferation of mouse mammary epithelial cells. Endocrinology 138:2466-2473.
67. S. Wang and S. Z. Haslam (1994). Serum-free primary culture of normal mouse mammary epithelial and stromal cells. In Vitro Cell. Dev. Biol. 30A:859-866.
68. S. Z. Haslam and M. L. Levely (1985). Estrogen responsiveness of normal mouse mammary cells in primary cell culture: Association of mammary fibroblasts with estrogenic regulation of progesterone receptors. Endocrinology 116:1835-1844.
69. S. Z. Haslam (1986). Mammary fibroblast influence on normal mouse mammary epithelial cell responses to estrogen in vitro. Cancer Res. 46:310-316.
70. R. White, J. A. Lees, M. Needham, J. Ham, and M. Parker (1987). Structural organization and expression of the mouse estrogen receptor. Mol. Endocrinol. 1:735-744.
71. G. G. J. M. Kuiper, E. Enmark, M. Pelto-Huikko, S. Nilsson, and J.-Å. Gustafsson (1996). Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA 93:5925-5930.
72. G. G. J. M. Kuiper, B. Carlsson, K. Grandien, E. Enmark, J. Häggblad, S. Nilsson, and J.-Å. Gustafsson (1997). Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 123:863-870.
73. G. B. Tremblay, A. Tremblay, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, F. Labrie, and V. Giguère (1997). Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor β. Mol. Endocrinol. 11:353-365.
74. B. S. Katzenellenbogen and K. S. Korach (1997). Editorial: A new actor in the estrogen receptor drama-enter ER-β. Endocrinology 138:861-862.
75. K. Paech, P. Webb, G. G. J. M. Kuiper, S. Nilsson, J.-Å. Gustafsson, P. J. Kushner, and T. S. Scanlan (1997). Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science 277:1508-1510.
76. A. Huang, E. R. Leygue, L. Snell, L. C. Murphy, and P. H. Watson (1997). Expression of estrogen receptor variant messenger RNAs and determination of estrogen receptor status in human breast cancer. Am. J. Pathol. 150:1827-1833.
77. Q. X. Zhang, S. G. Hilsenbeck, S. A. Fuqua, and A. Borg (1996). Multiple splicing variants of the estrogen receptor are present in individual human breast tumors. J. Steroid Biochem. Mol. Biol. 59:251-260.
78. M. Sluyser (1994). Hormone resistance in cancer: The role of abnormal steroid receptors. Crit. Rev. Oncog. 5:539-554.
79. E. R. Leygue, P. H. Watson, and L. C. Murphy (1996). Estrogen receptor variants in normal human mammary tissue. J. Natl. Cancer Inst. 88:284-290.
80. U. Pfeffer (1996). Estrogen receptor mRNA variants. Do they have a physiological role? Ann. N.Y. Acad. Sci. 784:304-313.
81. U. Pfeffer, E. Fecarotta, G. Arena, A. Forlani, and G. Vidali (1996). Alternative splicing of the estrogen receptor primary transcript normally occurs in estrogen receptor positive tissues and cell lines. J. Steroid Biochem. Mol. Biol. 56:99-105.
82. C. G. Castles, S. A. W. Fuqua, D. M. Klotz, and S. M. Hill (1993). Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line. Cancer Res. 53:5934-5939.
83. D. R. Schott, G. Shyamala, W. Schneider, and G. Parry (1991). Molecular cloning, sequence analysis, and expression of complementary DNA encoding murine progesterone receptor. Biochemistry 30:7014-7020.
84. L. S. Dure, IV, W. T. Schrader, and B. W. O'Malley (1980). Covalent attachment of a progestational steroid to chick oviduct progesterone receptor by photoaffinity labeling. Nature 238:784-786.
85. K. B. Horwitz and P. S. Alexander (1983). In situ photo-linked nuclear progesterone receptors of human breast cancer cells: Subunit molecular weights after transformation and translocation. Endocrinology 113:2195-2210.
86. H. Loosfelt, F. Logeat, M. T. Vu Hai and E. Milgrom (1984). The rabbit progesterone receptor. Evidence for a single steroid-binding unit and characterization of receptor mRNA. J. Biol. Chem. 259:14196-14202.
87. 3H]R5020 photoaffinity labeling: evidence that the A and B subunits are not equimolar. Endocrinology 120:1449-1456.
88. W. Schneider, C. Ramachandran, P. G. Satyaswaroop, and G. Shyamala (1991). Murine progesterone receptor exists predominantly as the 83-kilodalton 'A' form. J. Steroid Biochem. Mol. Biol. 38:285-291.
89. E. Vegeto, M. M. Shahbaz, D. X. Wen, M. E. Goldman, B. W. O'Malley, and D. P. McDonnell (1993). Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. Mol. Endocrinol. 7:1244-1255.
90. W. L. Kraus, K. E. Weis, and B. S. Katzenellenbogen (1995). Inhibitory cross talk between steroid hormone receptors: differential targeting of estrogen receptor in the repression of its transcriptional activity by agonist- and antagonist-occupied progestin receptors. Mol. Cell. Biol. 15:1847-1857.
91. J. A. Katzenellenbogen, B. W. O'Malley, and B. S. Katzenellenbogen (1996). Tripartite steroid hormone receptor pharmacology: Interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. Mol. Endocrinol. 10:119-131.
92. B. W. O'Malley, W. T. Schrader, S. Mani, C. Smith, N. L. Weigel, O. M. Conneely, and J. H. Clark (1995). An alternative ligand-independent pathway for activation of steroid receptors. Rec. Prog. Horm. Res. 50:333-347.
93. T. J. A. Key and M. C. Pike (1988). The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur. J. Cancer Clin. Oncol. 24:29-43.
94. M. C. Pike, J. R. Daniels, and D. V. Spicer (1997). A hormonal contraceptive approach to reducing breast and ovarian cancer risk: An update. Endocrine-Related Cancer 4:125-133.
95. I. Russo and I. H. Russo (1997). Role of differentiation in the pathogenesis and prevention of breast cancer. Endocrine-Related Cancer 4:7-21.
96. I. H. Russo and J. Russo (1996). Mammary gland neoplasia in long-term rodent studies. Environ. Health Perspect. 104:938-967.